Previous studies showed that miR-612 inhibited the capacity of tumorigenesis and metastasis of HCC by targeting AKT2.21, 22 Here we extended these findings to CRC occurrence and development, the underlying mechanism of which in not new. The gene discussed is AKT2; the disease is colorectal carcinoma.